Immuno-Oncology for Pancreatic Cancer: A Combination Clinical Trial with Chemotherapy and Radiation

Information

• Research Project
• 9742032

• ApplicationId

  9742032

• Core Project Number

  R44CA203336

• Full Project Number

  4R44CA203336-02

• Serial Number

  203336

• FOA Number

  PA-14-071

• Sub Project Id

• Project Start Date

  12/23/2015 - 8 years ago

• Project End Date

  7/31/2021 - 2 years ago

• Program Officer Name

  EVANS, GREGORY

• Budget Start Date

  8/1/2018 - 5 years ago

• Budget End Date

  7/31/2019 - 4 years ago

• Fiscal Year

  2018

• Support Year

  02

• Suffix

• Award Notice Date

  7/26/2018 - 5 years ago

Organizations

• ADVANTAGENE, INC

IC Name

• Activity

  R44

• Administering IC

  CA

• Application Type

  4

• Direct Cost Amount

• Indirect Cost Amount

• Total Cost

  659516

• Sub Project Total Cost

• ARRA Funded

  False

• CFDA Code

  395

• Ed Inst. Type

• Funding ICs

  NCI:659516\

• Funding Mechanism

  SBIR-STTR RPGs

• Study Section

  ZRG1

• Study Section Name

  Special Emphasis Panel

• Organization Name

  ADVANTAGENE, INC

• Organization Department

• Organization DUNS

  192959851

• Organization City

  AUBURNDALE

• Organization State

  MA

• Organization Country

  UNITED STATES

• Organization Zip Code

  024661923

• Organization District

  UNITED STATES